| 2016 | Predictive capacity of a non-radioisotopic local lymph node assay using flow cytometry, LLNA: BrdU-FCM: Comparison of a cutoff approach and inferential statistics | 배승진; 임경민 | Article |
| 2016 | Eight-year experience of using HTA in drug reimbursement: South Korea | 배승진 | Article |
| 2019 | Me-too validation study for in vitro eye irritation test with 3D-reconstructed human cornea epithelium, MCTT HCE TM | 배승진; 임경민 | Article |
| 2013 | A cross-sectional study of factors related to gastrointestinal drug use in Korean adolescents | 곽혜선; 이병구; 이정연; 배승진 | Article |
| 2020 | Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries? | 배승진 | Article |
| 2020 | Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea | 배승진; 이동환; 손경복 | Article |
| 2020 | The Burden of Cervical Cancer in Korea: A Population-Based Study | 배승진; 이동환; 손경복 | Article |
| 2015 | Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins | 배승진; 임경민 | Letter |
| 2014 | Sourcing quality-of-life weights obtained from previous studies: Theory and reality in Korea | 배승진 | Review |
| 2018 | Response to Letter to the Editor on our paper "Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4" by Ha et al. (Submitted 25 Jun 2017) | 배승진; 임경민 | Letter |
